Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
about
Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patientsClostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in IndiaUse of antibiotics in the treatment of Crohn's diseaseInnate immunity in inflammatory bowel disease: a disease hypothesisMultidrug Resistance Is Common in Escherichia coli Associated with Ileal Crohnʼs DiseaseProbiotics for maintenance of remission in ulcerative colitisProbiotics for maintenance of remission in ulcerative colitisReduced Paneth cell alpha-defensins in ileal Crohn's diseaseSide-stream smoking reduces intestinal inflammation and increases expression of tight junction proteinsLactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitisMicrobiota-based treatments in alcoholic liver diseaseModulating Composition and Metabolic Activity of the Gut Microbiota in IBD PatientsFecal microbiota transplantation: in perspectiveThe Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal MicrobiotaRole of antibiotics for treatment of inflammatory bowel diseaseAntioxidant therapy for treatment of inflammatory bowel disease: Does it work?The Intestinal Microbiota in Inflammatory Bowel DiseaseThe use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American expertsGut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectivesIndividualized medicine and the microbiome in reproductive tractIntestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel diseasePathobionts of the gastrointestinal microbiota and inflammatory diseaseVitamin D, immune regulation, the microbiota, and inflammatory bowel diseaseNutritional protective mechanisms against gut inflammationContributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip.Characterization of the core rumen microbiome in cattle during transition from forage to concentrate as well as during and after an acidotic challengeMolecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesTight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigmsAdministration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in ratsThe gut microbiota shapes intestinal immune responses during health and diseaseReduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approachEnteric pathogens through life stages.A2B adenosine receptor gene deletion attenuates murine colitis.Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.A key role of dendritic cells in probiotic functionality.Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
P2860
Q21195017-9E227A52-D94B-444F-B368-C2EA6E7C0F46Q21261889-27A7DDFC-22AB-4811-9593-2D69320FA784Q22241216-5E368904-57A1-42AD-A816-5C9D3CA69006Q22252859-CB6F95A1-3422-4A1F-A3E3-4F4CA3A723B3Q22252899-99F0CEA6-4429-4532-95B9-A4AA417D7B08Q24234400-E4EDA218-EAA3-469B-A5C7-FB4A6A1B3EC2Q24242289-EBD68450-E1D6-4347-B59A-BF9380B3DB2FQ24538724-D901A255-3C4E-485F-8973-36BA38E5098BQ24621817-2459D9D2-032C-436E-A62F-111AA267BB41Q24652503-0DC9F531-0E1E-409C-94F2-9962EE277A00Q26740192-963A73D3-BB6D-4B96-A540-3E88F9F975B8Q26750985-36C12D1F-E1A2-4354-867F-F5869D3FE13FQ26765214-18A450FC-EF48-47E6-B8BF-FA4512F20706Q26773227-ABCE20F2-BE0C-474F-9D40-1E5D731699C7Q26774552-5159E428-5E60-4352-B9AA-E47CD28416E3Q26777641-ABB190AE-0F5A-4116-890B-055F36C7E513Q26795705-3BB3114E-CDC3-4F3C-8345-8B3D3C7B4CF8Q26823347-9F268EAA-A63B-469B-AB45-66543BAD49ABQ26864127-FD7579C8-0455-423F-A9DC-719A1E1BBA10Q26999090-17221815-54E8-4350-B2F8-5BF7EDB21764Q27003192-121B038E-71AA-4DBD-A78D-98DCA7153640Q27008113-988E954B-5186-4B0A-940F-81FB416591B7Q27014906-F04AC119-504D-41DF-99E1-2C4075AD782AQ27028202-51699ABB-BF5A-4FA6-B9E0-0AA85C112863Q27316911-4FAA8317-B4D1-4555-A433-7462367243D0Q27339851-F3F9C008-2FE4-477D-BC4C-D373803D6989Q28131810-A9E7AAEF-B5A9-4198-A698-8B2B78D3D715Q28249095-864A76E9-2535-4946-A942-2459E1BEA797Q28539513-C2FBF231-BF43-45EA-99D1-120300B7AD8EQ29547727-72C7F212-4F1E-49F4-B129-E6DB069C882EQ29617547-1C5B41F6-5C9C-4DB3-8155-79B41986EFEFQ30425379-BEC7376A-1F8E-42D3-861C-A86B01B52FC9Q30438772-EC0F6478-9237-49DE-94F8-EF9164ABF26AQ30490594-25F0427C-12EC-4DB3-803C-FC07D341AC4BQ30830505-6696280E-21C2-4A11-9CAC-5014CC879B52Q30945619-230839AC-BCE8-4AA9-BE49-75B40EA53255Q31160841-567D0627-0712-42DF-BD21-AE78B2C415DBQ33270858-91D658CA-D871-4DE6-9103-9B16CD7BEF76Q33296911-E00D23A6-0D4E-481F-8365-883CE30E1759Q33309955-3EBFDB19-1527-41B6-A760-4B331556DF77
P2860
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Therapeutic manipulation of th ...... s, probiotics, and prebiotics.
@ast
Therapeutic manipulation of th ...... s, probiotics, and prebiotics.
@en
type
label
Therapeutic manipulation of th ...... s, probiotics, and prebiotics.
@ast
Therapeutic manipulation of th ...... s, probiotics, and prebiotics.
@en
prefLabel
Therapeutic manipulation of th ...... s, probiotics, and prebiotics.
@ast
Therapeutic manipulation of th ...... s, probiotics, and prebiotics.
@en
P1433
P1476
Therapeutic manipulation of th ...... s, probiotics, and prebiotics.
@en
P2093
R Balfour Sartor
P304
P356
10.1053/J.GASTRO.2004.03.024
P407
P577
2004-05-01T00:00:00Z